Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived) in cancer patients with fever and neutropenia

This publication has 11 references indexed in Scilit:

• Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer
  Cancer, 1993
• Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy
  European Journal Of Cancer, 1993
• Recombinant human granulocyte‐macrophage colony‐stimulating factor after autologous bone marrow transplantation for malignant lymphoma: a British National Lymphoma Investigation double‐blind, placebo‐controlled trial
  British Journal of Haematology, 1992
• Recombinant human granulocyte-macrophage colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation with unpurged and purged marrow in non-Hodgkin's lymphoma: a double- blind placebo-controlled trial
  Blood, 1992
• Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor
  New England Journal of Medicine, 1992
• Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor
  New England Journal of Medicine, 1992
• Infection risk in patients with small cell lung cancer receiving intensive chemotherapy and recombinant human granulocyte-macrophage colony-stimulating factor
  European Journal Of Cancer, 1992
• Effects of Bacterially Synthesized Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Patients with Advanced Malignancy
  Annals of Internal Medicine, 1989
• Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients
  The American Journal of Medicine, 1988
• Antibiotics in Patients With Neutropenia
  Archives of internal medicine (1960), 1984